BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1133@pharmaconomics
DTSTAMP:20260707T021632Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:LYEL PDUFA — ronde-cel (estimated date)
DESCRIPTION:The FDA's approval decision on ronde-cel for large B-cell lymphoma (LBCL) is due ~ Jan 1\, 2027. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1806952/000162828026031269/lyel-20260506x8kexx991.htm\n\nTrack it: https://pharmaconomics.com/e/1133
URL:https://pharmaconomics.com/e/1133
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:LYEL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR